The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in sprague-dawley rats
The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
The effect of morphine tolerance and withdrawal on prodynorphin peptides was studied in relevant brain areas and in the pituitary gland of male Sprague-Dawley rats, and compared with effects on the proenkephalin-derived peptide Met-enkephalin. After 8 days of morphine injections (twice daily), dynorphin A and B levels increased in the nucleus accumbens and dynorphin A levels increased also in the striatum. Morphine treatment increased striatal Met-enkephalin. Leu-enkephalinArg6 levels were reduced in the ventral tegmental area (VTA). Morphine-treated rats had very low Leu-enkephalinArg6 levels in the hippocampus as compared to saline control rats. Comparison of the relative amounts of dynorphin peptides and the shorter prodynorphin-derived peptides, Leu-enkephalinArg6 and Leu-enkephalin, revealed a relative increase in dynorphin peptides versus shorter fragments in the nucleus accumbens, VTA and hippocampus. Morphine-tolerant rats had lower levels of dynorphin A in both lobes of the pituitary gland, whereas hypothalamic dynorphin levels were unaffected by morphine. Leu-enkephalinArg6 levels were reduced in the hypothalamus, but not changed in the pituitary gland. Naloxone-precipitated withdrawal accentuated the increase in dynorphin A and B levels in the accumbens and dynorphin A levels in the striatum, while inducing an increase in enkephalin levels in the accumbens and Met-enkephalin in the VTA. In the hippocampus, Leu-enkephalinArg6 levels remained low in the withdrawal st…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Molecular mechanisms of drug addiction
Nestler, E. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.031 · Cited by 1,108
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04963.x · Cited by 539
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Nestler, E. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02439.1992 · Cited by 421
Weisskopf, M. G., Zalutsky, R. A., & Nicoll, R. A. (1993) · Nature · doi:10.1038/362423a0 · Cited by 336
McGinty, J. F., Henriksen, S. J., Goldstein, A., Terenius, L., & Bloom, F. E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.589 · Cited by 290
Self-citationOpiate reward: Sites and substrates
Wise, R. A. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80021-1 · Cited by 287
Some thoughts on the significance of enkephalin, the endogenous ligand
Kosterlitz, H. W., & Hughes, J. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90243-x · Cited by 275
Wagner, J. J., Terman, G. W., & Chavkin, C. (1993) · Nature · doi:10.1038/363451a0 · Cited by 271
Inhibition of opiate tolerance by non-competitive N-d-aspartate receptor antagonists
Trujillo, K. A., & Akil, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91538-5 · Cited by 195
Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
Tulunay, F. C., Jen, M. F., Chang, J. K., Loh, H. H., & Lee, N. M. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32800-4 · Cited by 171
Christensson-Nylander, I., Herrera-Marschitz, M., Staines, W., H�kfelt, T., Terenius, L., Ungerstedt, U., Cuello, C., Oertel, W. H., & Goldstein, M. (1986) · Experimental Brain Research · doi:10.1007/bf00238213 · Cited by 169
Self-citationHurd, Y. L., & Herkenham, M. A. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90198-k · Cited by 160
Ben‐Eliyahu, S., Marek, P., Vaccarino, A. L., Mogil, J. S., Sternberg, W. F., & Liebeskind, J. C. (1992) · Brain Research · doi:10.1016/0006-8993(92)90094-p · Cited by 153
Dynorphin: A possible modulatory peptide on morphine or β-endorphin analgesia in mouse
Friedman, H. J., Jen, M.-F., Chang, J. K., Lee, N. M., & Loh, H. H. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90483-0 · Cited by 143
Fratta, W., Yang, H., Hong, J., & Costa, E. (1977) · Nature · doi:10.1038/268452a0 · Cited by 139
Characterization of the prodynorphin and proenkephalin neuropeptide systems in rat hippocampus
Chavkin, C., Shoemaker, W., McGinty, J., Bayon, A., & Bloom, F. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-03-00808.1985 · Cited by 133
Engber, T. M., Boldry, R. C., Kuo, S., & Chase, T. N. (1992) · Brain Research · doi:10.1016/0006-8993(92)90716-m · Cited by 128
Striato-nigral dynorphin and substance P pathways in the rat
Herrera‐Marschitz, M., Christensson-Nylander, I., Sharp, T., Staines, W. A., Reid, M. S., H�kfelt, T., Terenius, L. Y., & Ungerstedt, U. (1986) · Experimental Brain Research · doi:10.1007/bf00238214 · Cited by 110
Self-citationLi, S. J., Jiang, H., Stachowiak, M. S., Hudson, P. M., Owyang, V., Nanry, K. P., Tilson, H. A., & Hong, J. (1990) · Molecular Brain Research · doi:10.1016/0169-328x(90)90020-e · Cited by 108
Morphine alters preproenkephalin gene expression
Uhl, G. R., Ryan, J. P., & Schwartz, J. P. (1988) · Brain Research · doi:10.1016/0006-8993(88)90658-0 · Cited by 106
Blockade of morphine-induced analgesia and tolerance in mice by MK-801
Lutfy, K., Hurlbut, D. E., & Weber, E. (1993) · Brain Research · doi:10.1016/0006-8993(93)90195-s · Cited by 98
Radioimmunoassay of enkephalins
WESCHE, D. L., H�llt, V., & Herz, A. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00501267 · Cited by 98
A general procedure for analysis of proenkephalin B derived opioid peptides
Christensson-Nylander, I., Nyberg, F., Ragnarsson, U., & Terenius, L. Y. (1985) · Regulatory Peptides · doi:10.1016/0167-0115(85)90032-1 · Cited by 94
Self-citationSuppression of withdrawal symptoms by dynorphin in heroin addicts
Wen, H. L., & Ho, W. K. K. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90509-x · Cited by 92
Enkephalin: Radioimmunoassay and radioreceptor assay in morphine dependent rats
Childers, S. R., Simantov, R., & Snyder, S. H. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90346-6 · Cited by 88
Kappa receptors mediate the peripheral aversive effects of opiates
Bechara, A., & van der Kooy, D. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90219-x · Cited by 81
Chavkin, C., Bakhit, C., Weber, E., & Bloom, F. E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7669 · Cited by 76
Suppression by dynorphin A-(1–13) of the expression of opiate withdrawal and tolerance in mice
Takemori, A. E., Loh, H. H., & Lee, N. M. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90705-9 · Cited by 76
Nyberg, F., Nordström, K., & Terenius, L. Y. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90199-8 · Cited by 75
Self-citationDynorphin-(1–13): Effects in nontolerant and morphine-dependent rhesus monkeys
Aceto, M. D. G., Dewey, W. L., Chang, J.-K., & Lee, N. M. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90299-0 · Cited by 72
Green, P. G., & Lee, N. M. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90429-3 · Cited by 70
Pickel, V. M., Chan, J., & Sesack, S. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90693-h · Cited by 63
Schmauss, C., & Herz, A. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90695-9 · Cited by 62
Seizinger, B. R., Höllt, V., & Herz, A. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91507-2 · Cited by 62
Gudehithlu, K. P., Tehwani, G. A., & Bhargava, H. N. (1991) · Brain Research · doi:10.1016/0006-8993(91)90836-k · Cited by 58
Rattan, A. K., Koo, K. L., Tejwani, G. A., & Bhargava, H. N. (1992) · Brain Research · doi:10.1016/0006-8993(92)90896-h · Cited by 57
Regulation of striatonigral prodynorphin peptides by dopaminergic agents
Trujillo, K. A., Day, R. W., & Akil, H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90977-j · Cited by 56
Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain
Romualdi, P., Lesa, G. M., & Ferri, S. S. (1991) · Brain Research · doi:10.1016/0006-8993(91)91525-6 · Cited by 56
Bergström, L., Christensson, I., Folkesson, R., Stenström, B., & Terenius, L. Y. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90703-8 · Cited by 52
Self-citationOlson, G. A., Olson, R. D., Kastin, A. J., & Coy, D. H. (1982) · Peptides · doi:10.1016/0196-9781(82)90075-4 · Cited by 52
Dopamine receptors mediate alterations in striato-nigral dynorphin and substance p pathways
Nylander, I., & TERENIUS, L. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90090-6 · Cited by 51
Self-citationOlson, G. A., Olson, R. D., & Kastin, A. J. (1992) · Peptides · doi:10.1016/0196-9781(92)90036-3 · Cited by 48
Hippocampal μ-receptors mediate opioid reinforcement in the CA3 region
Stevens, K. E., Shiotsu, G., & Stein, L. (1991) · Brain Research · doi:10.1016/0006-8993(91)91263-z · Cited by 40
Immunoreactive dynorphin in the rat adenohypophysis consists exclusively of 6000 dalton species
Seizinger, B. R., Höllt, V., & Herz, A. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91687-9 · Cited by 38
Increased neuropeptide-converting enzyme activities in cerebrospinal fluid of opiate-tolerant rats
Persson, S., Post, C., Alari, L., Nyberg, F., & Terenius, L. Y. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90838-0 · Cited by 37
Self-citationUnterwald, E. M., Tempel, A., Koob, G. F., & Zukin, R. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90120-0 · Cited by 36
Millan, M. H., Millan, M. J., & Herz, A. (2008) · Neuroendocrinology · doi:10.1159/000123877 · Cited by 36
Lasoń, W., Przewłocka, B., & Przewłocki, R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90090-x · Cited by 35
Khazan, N., Young, G. A., & Calligaro, D. O. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90564-7 · Cited by 35
Millan, M. J., Millan, M. H., & Herz, A. (2008) · Neuroendocrinology · doi:10.1159/000123473 · Cited by 30
Chronic administration of morphine decreases level of dynorphin a in the rat nucleus accumbens
Yukhananov, R. Y., Zhai, Q., Persson, S., Post, C., & Nyberg, F. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90084-g · Cited by 28
Differential effects of heroin on opioid levels in the rat brain
Weissman, B. A., & Zamir, N. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90506-1 · Cited by 22
Trujillo, K. A., & Akil, H. (1989) · PubMed · Cited by 20
Nylander, I. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90168-b · Cited by 20
Self-citationRaymon, H. K., Smith, T. D., & Leslie, F. M. (1992) · Brain Research · doi:10.1016/0006-8993(92)90142-v · Cited by 17
Ohno, M., Yamamoto, T., Araki, H., & Ueki, S. (1987) · Psychopharmacology · doi:10.1007/bf00217060 · Cited by 14
Morphine addiction does not alter brain or pituitary immunoreactive dynorphin level
Ho, W. K. K., Wan, C. C., Chan, W. Y., Cheung, W. K., Kwok, K. Y., & Wen, H. L. (1982) · Pharmacological Research Communications · doi:10.1016/s0031-6989(82)80010-6 · Cited by 7
Changes in the prodynorphin system after chronic morphine treatments in vitro
Vlaskovska, M. V., Geijer, T., Nylander, I., Silberring, J., & Terenius, L. Y. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90350-6 · Cited by 4
Self-citation
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“For opioids, animal studies have demonstrated region-specific increases in the levels of dynorphin after the passive administration of morphine (Nylander et al., 1995) and heroin (Weissman and Zamir, 1987).”
BackgroundAn essential role for ΔFosB in the nucleus accumbens in morphine action
Zachariou, V., Bolanos, C. A., Selley, D. E., Theobald, D., Cassidy, M. P., Kelz, M. B., Shaw-Lutchman, T., Berton, O., Sim-Selley, L. J., Dileone, R. J., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1636 · Cited by 266
Gardell, L. R., Wang, R., Burgess, S. E., Ossipov, M. H., Vanderah, T. W., Malan, T. P., Lai, J., & Porreca, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06747.2002 · Cited by 261
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0844-x · Cited by 180
“Like other drugs of abuse, opiate treatment has been shown to alter DYN/KOR systems in reward-related neural circuits in animal models [376].”
BackgroundSchlosburg, J. E., Whitfield, T. W., Park, P. E., Crawford, E. F., George, O., Vendruscolo, L. F., & Koob, G. F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1979-13.2013 · Cited by 119
“Additionally, animal studies have demonstrated region-specific increases in gene expression of the precursor preprodynorphin (Tjon et al., 1997), leading to increased levels of dynorphin, following passive administration of morphine (Nylander et al., 1995) and heroin (Weissman and Zamir, 1987).”
BackgroundInfluential
Metadata
- Authors
- Nylander, I., Vlaskovska, M., & Terenius, L.
- Affiliations
- Karolinska Institutet (SE)
- ORCID
- Terenius, L.
- Venue
- Psychopharmacology
- Published
- 1995-04
- Volume
- 118
- Issue
- 4
- Pages
- 391-400
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2044963578
- Cited by
- 61
- References
- 65
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 6 · 2020: 4 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- National Institute on Drug Abuse
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- morphine tolerance, morphine withdrawal, dynorphin, enkephalin, prodynorphin, met-enkephalin, nucleus accumbens, ventral tegmental area, hippocampus, pituitary gland, striatum, naloxone-precipitated withdrawal, opioid peptides
- MeSH terms
- Analysis of Variance, Animals, Drug Tolerance, Dynorphins, Endorphins, Enkephalin, Leucine, Male, Morphine, Naloxone, Peptides, Substance Withdrawal Syndrome, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.